Opus Genetics IRD Q4 2025 Annual earnings
Reported May 21, 2026 · Before market open
Revenue estimate$3.1M
EPS estimate-$0.16
Next report
Aug 12, 2026 (in a month)Revenue estimate$2.6M
EPS estimate-$0.15
Financials
Q4 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Opus Genetics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Opus Genetics report Q4 2025 earnings?
- Opus Genetics (IRD) reported Q4 2025 earnings on May 21, 2026 before market open.
- What were Opus Genetics's Q4 2025 revenue and EPS?
- Opus Genetics reported revenue of $3.9M and diluted EPS of $-0.19 for Q4 2025.
- Did Opus Genetics beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $3.1M by $721.0K. EPS missed the consensus estimate of $-0.16 by $0.03.
- How did Opus Genetics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 10.2% from $4.3M a year earlier and diluted EPS grew 85.0% from $-1.27.
- Where can I find Opus Genetics's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001140361-26-009247) directly on SEC EDGAR. The filing index links above go to sec.gov.